A Study to Evaluate the Long-term Safety and Tolerability of Lu AF20513 and the Antibody Response in Patients With Alzheimer's Disease (AD)

Summary

The purpose of this study is to evaluate the long-term safety, tolerability and antibody response of Lu AF20513 in patients with Alzheimer's disease who have completed the 16026A study.

Timeline

Start

2018-06-26

Primary completion

2019-05-27

Completion

2019-05-27

Outcome

Outcome not reported

Stopped: “New data: The study was terminated based on new efficacy data from another study”

Drugs

Indications